La Regione “Covid, un’economia comunque resiliente” Tavola rotonda Abt, ospite il presidente di Farma Industria Ticino, Giorgio Calderari

25 March 2021

3B FUTURE HEALTH GP S.A.R.L. ANNOUNCES THE LAUNCH OF 3B FUTURE HEALTH FUND II

24 March 2021

Taiho Pharmaceutical Submits New Drug Application for NK1 Receptor Antagonist Fosnetupitant for Prevention of Gastrointestinal Symptoms (Nausea and Vomiting) Associated with Cancer Chemotherapy

23 March 2021

Gain Therapeutics Announces Pricing of Initial Public Offering of Common Stock

22 March 2021

Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world setting

18 March 2021

Teleticino – “Facevamo tamponi di massa già da tempo” Intervista a Giorgio Calderari, presidente FIT e Group General Manager di Helsinn

16 March 2021

Creare alleanze produttive per i vaccini – L’opinione del Presidente FIT Giorgio Calderari

26 February 2021

Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy and safety

18 February 2021

Il rebus vaccini, tra ritardi e polemiche sui brevetti – Intervista a Giorgio Calderari, Presidente FIT

15 February 2021

Pharma Boardroom – Interview to Giorgio Calderari – Chairman, Farma Industria Ticino (FIT)

15 February 2021